404 related articles for article (PubMed ID: 22701481)
1. Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.
Gati CD; Mortari MR; Schwartz EF
J Toxicol; 2012; 2012():756358. PubMed ID: 22701481
[TBL] [Abstract][Full Text] [Related]
2. Potassium channel blockers and openers as CNS neurologic therapeutic agents.
Judge SI; Smith PJ; Stewart PE; Bever CT
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):200-28. PubMed ID: 18221232
[TBL] [Abstract][Full Text] [Related]
3. Venom-derived peptides inhibiting Kir channels: Past, present, and future.
Doupnik CA
Neuropharmacology; 2017 Dec; 127():161-172. PubMed ID: 28716449
[TBL] [Abstract][Full Text] [Related]
4. Arthropod toxins acting on neuronal potassium channels.
Jiménez-Vargas JM; Possani LD; Luna-Ramírez K
Neuropharmacology; 2017 Dec; 127():139-160. PubMed ID: 28941737
[TBL] [Abstract][Full Text] [Related]
5. The voltage-gated potassium channel K
Tajti G; Wai DCC; Panyi G; Norton RS
Biochem Pharmacol; 2020 Nov; 181():114146. PubMed ID: 32653588
[TBL] [Abstract][Full Text] [Related]
6. Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders.
Qiu Q; Yang M; Gong D; Liang H; Chen T
Neural Regen Res; 2024 Jun; ():. PubMed ID: 38845230
[TBL] [Abstract][Full Text] [Related]
7. Versatile spider venom peptides and their medical and agricultural applications.
Saez NJ; Herzig V
Toxicon; 2019 Feb; 158():109-126. PubMed ID: 30543821
[TBL] [Abstract][Full Text] [Related]
8. Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins.
Kuzmenkov AI; Grishin EV; Vassilevski AA
Biochemistry (Mosc); 2015 Dec; 80(13):1764-99. PubMed ID: 26878580
[TBL] [Abstract][Full Text] [Related]
9. Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.
Klint JK; Senff S; Rupasinghe DB; Er SY; Herzig V; Nicholson GM; King GF
Toxicon; 2012 Sep; 60(4):478-91. PubMed ID: 22543187
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of venom peptides.
Lewis RJ; Garcia ML
Nat Rev Drug Discov; 2003 Oct; 2(10):790-802. PubMed ID: 14526382
[TBL] [Abstract][Full Text] [Related]
11. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment.
Judge SI; Bever CT
Pharmacol Ther; 2006 Jul; 111(1):224-59. PubMed ID: 16472864
[TBL] [Abstract][Full Text] [Related]
12. Structure Activity Relationship of Venom Toxins Targeting Potassium Channels.
Batool S; Noureen N; Kamal MA
Curr Drug Metab; 2018; 19(8):714-720. PubMed ID: 29283069
[TBL] [Abstract][Full Text] [Related]
13. Peptide toxins and small-molecule blockers of BK channels.
Yu M; Liu SL; Sun PB; Pan H; Tian CL; Zhang LH
Acta Pharmacol Sin; 2016 Jan; 37(1):56-66. PubMed ID: 26725735
[TBL] [Abstract][Full Text] [Related]
14. L-type voltage-dependent calcium channels as therapeutic targets for neurodegenerative diseases.
Yagami T; Kohma H; Yamamoto Y
Curr Med Chem; 2012; 19(28):4816-27. PubMed ID: 22834820
[TBL] [Abstract][Full Text] [Related]
15. Sodium Channels and Venom Peptide Pharmacology.
Israel MR; Tay B; Deuis JR; Vetter I
Adv Pharmacol; 2017; 79():67-116. PubMed ID: 28528674
[TBL] [Abstract][Full Text] [Related]
16. [Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers].
Devaux J; Beeton C; Béraud E; Crest M
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S16-27. PubMed ID: 15269656
[TBL] [Abstract][Full Text] [Related]
17. Venom-derived peptide inhibitors of voltage-gated potassium channels.
Norton RS; Chandy KG
Neuropharmacology; 2017 Dec; 127():124-138. PubMed ID: 28689025
[TBL] [Abstract][Full Text] [Related]
18. K(+) channels as therapeutic drug targets.
Wickenden A
Pharmacol Ther; 2002; 94(1-2):157-82. PubMed ID: 12191600
[TBL] [Abstract][Full Text] [Related]
19. Block of voltage-gated calcium channels by peptide toxins.
Bourinet E; Zamponi GW
Neuropharmacology; 2017 Dec; 127():109-115. PubMed ID: 27756538
[TBL] [Abstract][Full Text] [Related]
20. Target promiscuity and heterogeneous effects of tarantula venom peptides affecting Na+ and K+ ion channels.
Redaelli E; Cassulini RR; Silva DF; Clement H; Schiavon E; Zamudio FZ; Odell G; Arcangeli A; Clare JJ; Alagón A; de la Vega RCR; Possani LD; Wanke E
J Biol Chem; 2010 Feb; 285(6):4130-4142. PubMed ID: 19955179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
